CI - Cigna Corporation

NYSE - NYSE Delayed Price. Currency in USD
188.34
+0.15 (+0.08%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close188.19
Open189.13
Bid173.00 x 2900
Ask193.00 x 900
Day's Range187.38 - 189.38
52 Week Range163.02 - 227.13
Volume1,805,739
Avg. Volume2,232,814
Market Cap45.835B
Beta0.77
PE Ratio (TTM)18.37
EPS (TTM)10.26
Earnings DateNov 1, 2018
Forward Dividend & Yield0.04 (0.02%)
Ex-Dividend Date2018-03-09
1y Target Est223.06
Trade prices are not sourced from all markets
  • Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift
    Yahoo Finance Video5 days ago

    Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift

    Cigna, Express Scripts, Nvidia, McDonald’s and Twitter are the companies to watch.

  • Yahoo Finance Live: Market Movers - Aug 14th, 2018
    Yahoo Finance Video5 days ago

    Yahoo Finance Live: Market Movers - Aug 14th, 2018

    Yahoo Finance's LIVE stock market coverage and analysis.

  • Icahn drops fight against Cigna-Express Scripts deal
    CNBC Videos5 days ago

    Icahn drops fight against Cigna-Express Scripts deal

    Carl Icahn dropped his fight against the Cigna-Express Scripts deal citing the crossover was too big.

  • Investopedia2 days ago

    Carl Icahn Increased Position in Herbalife, Entered Cigna: 13F

    For billionaire investment titan Carl Icahn, the second quarter of the year was a busy one. According to a filing submitted to the SEC earlier this week, Icahn increased his stake in troubled nutrition company Herbalife Nutrition Ltd ( HLF) as well as his own namesake Icahn Enterprises LP ( IEP), per a report by Proactive Investors. While it's difficult to say whether or not any given position in the billionaire's portfolio could be the target of activist maneuvering, there are at least three major companies representing new positions in Icahn's portfolio during the second quarter of the year.

  • PR Newswire2 days ago

    Express Scripts Reminds Stockholders to Vote "FOR" the Merger with Cigna

    ST. LOUIS, Aug. 16, 2018 /PRNewswire/ -- Express Scripts (ESRX) today reminded its stockholders to vote "FOR" Express Scripts' merger agreement with Cigna (CI) at the Express Scripts' upcoming Special Meeting of Stockholders (the "Special Meeting") that is scheduled to be held on August 24, 2018, at 9:00 a.m. CT. Express Scripts stockholders who have any questions or need assistance voting their shares should call (800) 690-6903.

  • Benzinga3 days ago

    M&Ain't: Several Of The Year's Biggest Mergers Face Uncertain Future

    The high failure rate is a direct result of companies' inability to determine the strategic purpose of deals and how specific plans will enhance or stunt growth, according to the Harvard study.  AT&T/Time Warner Inc. AT&T Inc. (NYSE: T)’s $85-billion acquisition of Time Warner Inc. faced significant headwinds earlier this year as the Justice Department sued to block the potential merger. The reasoning for the DOJ’s decision was rooted in the deal's effect on consumers.

  • Thomson Reuters StreetEvents4 days ago

    Edited Transcript of CI earnings conference call or presentation 2-Aug-18 12:30pm GMT

    Q2 2018 Cigna Corp Earnings Call

  • MarketWatch4 days ago

    Carl Icahn starts positions in Cigna, Dell, VMware

    MARKET PULSE Activist investor Carl Icahn started a few new positions over the last quarter and added to his stakes in Icahn Enterprises LP (iep) and Herbalife Nutrition Ltd. (hlf) according to a filing with the Securities and Exchange Commission late Tuesday.

  • Icahn's Retreat May Hand Cigna a Pyrrhic Victory
    Bloomberg5 days ago

    Icahn's Retreat May Hand Cigna a Pyrrhic Victory

    Cigna Corp. won an unusual and very fast victory against Carl Icahn. The activist investor announced Monday night that he was dropping his nascent effort to block the health insurer’s $54 billion takeover of pharmacy benefit management giant Express Scripts Holding Co. Cigna may end up regretting its win,  though.

  • Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift
    Yahoo Finance5 days ago

    Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift

    Cigna, Express Scripts, Nvidia, McDonald’s and Twitter are the companies to watch.

  • Icahn won't solicit votes against Cigna-Express Scripts deal
    American City Business Journals5 days ago

    Icahn won't solicit votes against Cigna-Express Scripts deal

    The octogenarian investor originally opposed the deal due to the competitive risk Express Scripts and Cigna now face from Amazon.

  • Icahn ends Cigna-Express Scripts campaign, shares bounce
    Associated Press5 days ago

    Icahn ends Cigna-Express Scripts campaign, shares bounce

    Shares of Express Scripts are moving higher before the opening bell after activist investor Carl Icahn ended a short-lived fight to scuttle Cigna's takeover of the pharmacy benefit manager. Icahn said late Monday that he'll end his campaign to convince Cigna shareholders to vote against the roughly $52-billion deal this month. Icahn argued in a lengthy letter to fellow shareholders last week that Cigna was "dramatically overpaying" for Express Scripts.

  • Icahn abandons fight against Express Scripts-Cigna deal
    American City Business Journals5 days ago

    Icahn abandons fight against Express Scripts-Cigna deal

    Investor Carl Icahn will stop his efforts to fight Cigna's pending $54 billion acquisition of St. Louis-based Express Scripts Holding Co.

  • TheStreet.com5 days ago

    Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

    U.S. stock futures rose on Tuesday, Aug. 14, as investors cautiously returned to risk markets amid a stabilization in Turkey's currency crisis. Turkey's lira, which has been at the center of a one-week currency crisis that has rippled through financial markets all over the world, gained around 3% against the U.S. dollar in overnight trading. Indications were that moves by Turkey's central bank to stem the lira's decline likely will hold the currency in place while President Recep Tayyip Erdoğan negotiates the potential release of the American evangelical pastor Andrew Brunson, whom Ankara has accused of being involved in a failed 2016 coup.

  • Financial Times5 days ago

    [$$] Carl Icahn backs down over opposition to Cigna-Express Scripts deal

    to Cigna’s $67bn acquisition of Express Scripts, only a week after launching a withering attack that branded the deal “inexplicably ridiculous”. Mr Icahn’s climbdown ahead of a shareholder vote on August 24 follows expressions of support for the deal from the influential proxy advisers ISS and Glass Lewis, as well as backing for the takeover from Larry Robbins’s Glenview Capital Management hedge fund. Previously short Express Scripts stock, Mr Icahn said last week that “the only shareholders we believe would vote for this very risky acquisition are those who also own Express Scripts and are desperate to save it even at the expense of losing a great deal of value in their Cigna investment”.

  • Reuters5 days ago

    PRESS DIGEST- Wall Street Journal - Aug 14

    The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Elon Musk said Saudi Arabia's sovereign-wealth fund has approached ...

  • Financial Times5 days ago

    [$$] M&A/activists: Carl cools it

    Nothing is guaranteed to terrify a chief executive more than Carl Icahn tweeting about his or her company. It does not have to be that way. Last week Mr Icahn expressed his opposition to Cigna's pending ...

  • The Wall Street Journal5 days ago

    [$$] Icahn Backs Down on Cigna-Express Scripts Deal

    Carl Icahn no longer plans to solicit votes from Cigna Corp. shareholders against the health insurer’s $54 billion deal to buy Express Scripts Holding Co. after two proxy-advisory firms recommended shareholders support the deal, the billionaire activist investor said in a statement Monday. It called his opposition “misguided and shortsighted” in a statement last week.

  • Reuters5 days ago

    Icahn reverses position on Cigna-Express Scripts deal

    Icahn's comments come after proxy advisory firms Glass Lewis & Co and Institutional Shareholder Services Inc (ISS), as well as hedge fund Glenview Capital Management, extended their support for the deal. "In light of the ISS and Glass Lewis recommendations in favor of the Cigna/Express Scripts transaction and the significant stockholder overlap between the two companies, we have informed the SEC (U.S. Securities and Exchange Commission) that we no longer intend to solicit proxies to vote against the transaction," Icahn said in a statement. The billionaire investor, who has a long position on Cigna and a short position on Express Scripts, has been vocal in his criticism of the deal and last week said Cigna (CI.N) was overpaying for Express Scripts (ESRX.O).

  • Icahn reverses position on Cigna-Express Scripts deal
    Reuters5 days ago

    Icahn reverses position on Cigna-Express Scripts deal

    Icahn's comments come after proxy advisory firms Glass Lewis & Co and Institutional Shareholder Services Inc (ISS), as well as hedge fund Glenview Capital Management, extended their support for the deal. "In light of the ISS and Glass Lewis recommendations in favour of the Cigna/Express Scripts transaction and the significant stockholder overlap between the two companies, we have informed the SEC (U.S. Securities and Exchange Commission) that we no longer intend to solicit proxies to vote against the transaction," Icahn said in a statement.

  • Bloomberg5 days ago

    Icahn Drops Fight to Block Cigna's Express Scripts Takeover

    Activist investor Carl Icahn has dropped his fight to block Cigna Corp.’s $54 billion acquisition of Express Scripts Holding Co. after two prominent shareholder advisory firms came out in support of the deal. Institutional Shareholder Services Inc. and Glass Lewis & Co. last week urged Cigna’s investors to support the takeover, saying it made sense from a financial and strategic perspective. Icahn had opposed the deal, saying it would be a “travesty” if it were to proceed.

  • Express Scripts-Cigna pending merger praised by proxy advisory firms
    American City Business Journals6 days ago

    Express Scripts-Cigna pending merger praised by proxy advisory firms

    Two proxy advisory firms have recommended that Express Scripts' and Cigna's shareholders vote in favor of their pending $54 billion merger.

  • PR Newswire6 days ago

    Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement with Cigna

    ST. LOUIS, Aug. 13, 2018 /PRNewswire/ -- Express Scripts (ESRX) today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote "FOR" Express Scripts' merger agreement with Cigna (CI) at Express Scripts' upcoming special meeting of stockholders scheduled for August 24, 2018.

  • Reuters6 days ago

    Cigna-Express Scripts deal gets backing from another proxy firm

    Billionaire activist investor Carl Icahn, who owns shares in Cigna, opposes the deal. On Friday, Institutional Shareholder Services Inc (ISS) had extended support to the deal. Glass Lewis found the merger to be strategically and financially compelling for Cigna shareholders, the health insurer said in a statement.

  • Reuters6 days ago

    Cigna-Express Scripts deal gets backing from another proxy firm

    Cigna Corp said Glass Lewis & Co on Monday recommended its shareholders vote in favour for the proposed $52 billion acquisition of pharmacy benefits manager Express Scripts, the second proxy advisory firm to support the deal. Billionaire activist investor Carl Icahn, who owns shares in Cigna, opposes the deal. On Friday, Institutional Shareholder Services Inc (ISS) had extended support to the deal.